Dimensional Fund Advisors LP Decreases Position in Kenvue Inc. (NYSE:KVUE)

Dimensional Fund Advisors LP lowered its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 12.4% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 15,012,245 shares of the company's stock after selling 2,116,148 shares during the period. Dimensional Fund Advisors LP owned approximately 0.78% of Kenvue worth $323,203,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. bought a new position in shares of Kenvue in the 3rd quarter worth approximately $2,944,816,000. FMR LLC lifted its stake in shares of Kenvue by 572.1% in the 3rd quarter. FMR LLC now owns 89,182,980 shares of the company's stock worth $1,790,794,000 after purchasing an additional 75,913,107 shares during the period. Wellington Management Group LLP lifted its stake in shares of Kenvue by 576.1% in the 3rd quarter. Wellington Management Group LLP now owns 71,686,830 shares of the company's stock worth $1,439,472,000 after purchasing an additional 61,084,123 shares during the period. Massachusetts Financial Services Co. MA lifted its stake in shares of Kenvue by 227.7% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 61,091,189 shares of the company's stock worth $1,226,711,000 after purchasing an additional 42,449,470 shares during the period. Finally, Morgan Stanley lifted its stake in shares of Kenvue by 4,057.4% in the 3rd quarter. Morgan Stanley now owns 31,162,614 shares of the company's stock worth $625,745,000 after purchasing an additional 30,413,040 shares during the period. Institutional investors own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. reduced their target price on shares of Kenvue from $25.00 to $24.00 and set an "overweight" rating for the company in a report on Friday, February 9th. Sanford C. Bernstein began coverage on shares of Kenvue in a report on Thursday, April 11th. They set an "underperform" rating and a $18.00 price objective for the company. The Goldman Sachs Group began coverage on shares of Kenvue in a report on Friday, March 1st. They set a "neutral" rating and a $20.00 price objective for the company. HSBC increased their price objective on shares of Kenvue from $20.00 to $21.00 and gave the company a "hold" rating in a report on Wednesday, May 8th. Finally, Royal Bank of Canada cut their price objective on shares of Kenvue from $25.00 to $24.00 and set an "outperform" rating for the company in a report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $24.38.

Kenvue Trading Down 0.9 %

KVUE traded down $0.18 during trading on Monday, reaching $20.36. The company had a trading volume of 20,846,225 shares, compared to its average volume of 17,118,197. The stock has a market cap of $38.98 billion and a P/E ratio of 26.08. The business has a 50 day simple moving average of $19.94 and a 200-day simple moving average of $20.13. Kenvue Inc. has a 52 week low of $17.82 and a 52 week high of $27.80. The company has a quick ratio of 0.68, a current ratio of 0.99 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.03. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $3.79 billion. Kenvue had a return on equity of 21.06% and a net margin of 9.63%. Kenvue's quarterly revenue was down 24.9% on a year-over-year basis. On average, equities analysts anticipate that Kenvue Inc. will post 1.15 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Wednesday, May 8th will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Tuesday, May 7th. This represents a $0.80 annualized dividend and a dividend yield of 3.93%. Kenvue's dividend payout ratio (DPR) is 102.56%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.